Fingerprint
Dive into the research topics of 'Single agent bevacizumab for myelofibrosis: Results of the myeloproliferative disorders research consortium trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Single agent bevacizumab for myelofibrosis: Results of the myeloproliferative disorders research consortium trial
Ruben A. Mesa, Richard T. Silver, Srdan Verstovsek, John Mascarenhas, Craig M. Kessler, Damiano Rondelli, Judy D. Goldberg, Roberto Marchioli, Erin P. Demakos, Lewis R. Silverman, Ronald Hoffman
Research output: Contribution to journal › Article › peer-review
10
Scopus
citations